Periodic Reporting for period 2 - T-NHL SUPRESSORS (Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma)

T cell non-Hodgkin lymphomas (T-NHLs) are highly aggressive malignancies that are largely resistant to conventional therapies. T-NHLs remain significantly understudied, and their pathogenic mechanisms are still not well defined. We recently identified the inhibitory immune...